tiprankstipranks
Advertisement
Advertisement

BCTX Stock Latest News

BriaCell gets FDA clearance for Bria-PROS+ study in prostate cancer
The FlyBriaCell gets FDA clearance for Bria-PROS+ study in prostate cancer
9d ago
BCTX
Source Rock Royalties Declares Monthly Dividend and Grants New RSUs
PremiumCompany Announcements
Source Rock Royalties Declares Monthly Dividend and Grants New RSUs
29d ago
BCTX
BriaCell announces Odette Cancer Centre joins Bria-IMT trial
PremiumThe Fly
BriaCell announces Odette Cancer Centre joins Bria-IMT trial
29d ago
BCTX
BriaCell arranges scalable manufacturing with Fujifilm Biotechnologies
PremiumThe Fly
BriaCell arranges scalable manufacturing with Fujifilm Biotechnologies
30d ago
BCTX
BriaCell Subsidiary Highlights Interim Results, Ongoing Losses
PremiumCompany Announcements
BriaCell Subsidiary Highlights Interim Results, Ongoing Losses
2M ago
8K
BCTX
BriaCell enters MoU with Uneedle for microneedle technology
PremiumThe FlyBriaCell enters MoU with Uneedle for microneedle technology
2M ago
BCTX
BriaCell Therapeutics Completes Equity Offering to Fund Operations
Premium
Company Announcements
BriaCell Therapeutics Completes Equity Offering to Fund Operations
2M ago
8K
BCTX
BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study
Premium
The Fly
BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study
3M ago
BCTX
BriaCell announces data from Bria-IMT at ASCO 2026
PremiumThe Fly
BriaCell announces data from Bria-IMT at ASCO 2026
3M ago
BCTX
BriaCell completes manufacturing for prostate cancer clinical supplies
PremiumThe Fly
BriaCell completes manufacturing for prostate cancer clinical supplies
3M ago
BCTX
BriaCell adds Penn Medicine as Phase 3 breast cancer study site
PremiumThe Fly
BriaCell adds Penn Medicine as Phase 3 breast cancer study site
3M ago
BCTX
BriaCell receives FDA clearance to initiate Bria-BRES+ trial
PremiumThe Fly
BriaCell receives FDA clearance to initiate Bria-BRES+ trial
3M ago
BCTX
BriaCell presents anti-cancer activity of Bria-OTS
PremiumThe FlyBriaCell presents anti-cancer activity of Bria-OTS
4M ago
BCTX
BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR
Premium
The Fly
BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR
4M ago
BCTX
BriaCell Therapeutics Reports Rising Losses and Funding Pressure
Premium
Company Announcements
BriaCell Therapeutics Reports Rising Losses and Funding Pressure
5M ago
8K
BCTX
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR
PremiumCompany Announcements
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR
5M ago
BCTX
BriaCell to present four posters at the 2026 AACR
PremiumThe Fly
BriaCell to present four posters at the 2026 AACR
5M ago
BCTX
BriaCell Shareholders Approve Auditors and Reelect Board
PremiumCompany Announcements
BriaCell Shareholders Approve Auditors and Reelect Board
5M ago
8K
BCTX
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting
PremiumCompany Announcements
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting
5M ago
BCTX
BriaCell Restructures Soluble CD80 Program via BriaPro Deal
PremiumCompany AnnouncementsBriaCell Restructures Soluble CD80 Program via BriaPro Deal
6M ago
8K
BCTX
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
Premium
Company Announcements
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
6M ago
BCTX
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
Premium
The Fly
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
6M ago
BCTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >